EcoR1 Capital as of June 30, 2019
Portfolio Holdings for EcoR1 Capital
EcoR1 Capital holds 38 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kura Oncology (KURA) | 10.5 | $104M | 5.3M | 19.69 | |
| Xencor (XNCR) | 9.7 | $96M | 2.3M | 40.93 | |
| Argenx Se (ARGX) | 8.3 | $82M | 581k | 141.58 | |
| Fibrogen | 8.2 | $81M | 1.8M | 45.18 | |
| Crispr Therapeutics (CRSP) | 7.7 | $76M | 1.6M | 47.10 | |
| Spark Therapeutics | 6.3 | $63M | 614k | 102.38 | |
| Mirati Therapeutics | 6.2 | $62M | 598k | 103.00 | |
| Dicerna Pharmaceuticals | 5.3 | $52M | 3.3M | 15.75 | |
| Ironwood Pharmaceuticals (IRWD) | 5.2 | $51M | 4.7M | 10.94 | |
| Morphic Hldg (MORF) | 4.5 | $45M | 2.3M | 19.82 | |
| Ultragenyx Pharmaceutical (RARE) | 3.2 | $32M | 498k | 63.50 | |
| Prevail Therapeutics Ord | 3.2 | $32M | 2.4M | 13.20 | |
| Atreca Inc Cl A (BCEL) | 2.8 | $28M | 1.5M | 18.84 | |
| Chiasma | 2.3 | $23M | 3.0M | 7.47 | |
| Harpoon Therapeutics | 1.8 | $18M | 1.3M | 13.00 | |
| Gossamer Bio (GOSS) | 1.7 | $17M | 772k | 22.18 | |
| ArQule | 1.4 | $14M | 1.3M | 11.01 | |
| Eiger Biopharmaceuticals | 1.2 | $12M | 1.1M | 10.60 | |
| Arcus Biosciences Incorporated (RCUS) | 1.2 | $12M | 1.5M | 7.92 | |
| Unity Biotechnology | 1.0 | $9.9M | 1.0M | 9.50 | |
| Cyclerion Therapeutics | 0.9 | $8.9M | 776k | 11.45 | |
| Prothena (PRTA) | 0.8 | $7.6M | 723k | 10.57 | |
| Rubius Therapeutics | 0.7 | $7.3M | 463k | 15.73 | |
| Assembly Biosciences | 0.7 | $6.7M | 498k | 13.49 | |
| Surface Oncology | 0.7 | $6.5M | 2.3M | 2.82 | |
| Mersana Therapeutics | 0.6 | $5.6M | 1.4M | 4.05 | |
| Curis | 0.6 | $5.5M | 3.0M | 1.86 | |
| Aquinox Pharmaceuticals | 0.5 | $5.3M | 2.3M | 2.36 | |
| Rhythm Pharmaceuticals (RYTM) | 0.5 | $4.9M | 223k | 22.00 | |
| Solid Biosciences | 0.5 | $4.8M | 827k | 5.75 | |
| Ngm Biopharmaceuticals | 0.5 | $4.6M | 317k | 14.64 | |
| Kezar Life Sciences | 0.5 | $4.5M | 583k | 7.71 | |
| Aduro Biotech | 0.3 | $2.7M | 1.8M | 1.54 | |
| Vericel (VCEL) | 0.2 | $2.5M | 131k | 18.89 | |
| Syros Pharmaceuticals | 0.2 | $2.3M | 249k | 9.26 | |
| Regulus Therapeutics | 0.1 | $1.4M | 1.1M | 1.25 | |
| Gamida Cell | 0.0 | $265k | 52k | 5.08 | |
| Tcr2 Therapeutics Inc cs | 0.0 | $231k | 16k | 14.34 |